Post-approval studies (Phase 4)Study completedNCT01056822
What this trial is testing
Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.
Who this might be right for
Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft
Novartis Pharmaceuticals 89